Status:
RECRUITING
BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Biliary Atresia
Cognitive Impairment
Eligibility:
All Genders
Up to 18 years
Brief Summary
Biliary atresia is the most severe form of cholestatic liver disease. The children have high morbidity and mortality and get devastating pruritus and fatigue, failure to thrive, progressive hepatic fa...
Eligibility Criteria
Inclusion
- Biliary atresia
- Tetralogy of Fallot
- Healthy controls
Exclusion
- \- Not able to participate in exams
Key Trial Info
Start Date :
March 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2040
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05399745
Start Date
March 1 2020
End Date
December 31 2040
Last Update
June 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark, 2100